跳至主要内容
临床试验/NCT03275207
NCT03275207Unknown4 期

a Randomized Controlled Trial of Dexmedetomidine on Chronic Postoperative Pain After Breast and Thoracic Surgery

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
120
试验地点
1
主要终点
the pain intensity measure

研究概览

简要总结

Chronic postoperative pain (CPSP) is common symptom in patients after surgery, seriously affected the quality of life. Accumulating evidences have demonstrated dexmedetomidine can improve chronic pain. However, the prevention of dexmedetomidine on CPSP remain uncertain.

详细描述

Chronic postoperative pain (CPSP) is defined as pain persisting at least 3 months after surgery. It is most common in patients who undergoing breast or thoracic surgery. Dexmedetomidine, a adrenergic α2 agonists, can alleviate the postoperative pain 24 h after surgery. In our study, patients were randomly assigned to one of the two group to receive 0.5mg/kg/h infusion dexmedetomidine (Group D, n=57) or normal saline (Group C, n=57). The pain scales were evaluated day 1, day 2, day 3, month 3, month 6 after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have been 18 to 65 yr old, and been scheduled for breast or thoracic surgery.

排除标准

  • Patients with limitations of self-expression or visual dysfunction or having emergency surgery, a severe psychiatric illness, or chronic pain problems in the chest area for longer than 2 months before the surgery,or patients who could not provide informed consent were excluded.
  • Pregnant women and prisoners were also excluded.

研究组 & 干预措施

control group

Placebo Comparator

an equal volume of saline

干预措施: saline (Drug)

dexmedetomidine

Experimental

dexmedetomidine, 0.5ug/kg/h by intravenous infusion, intraoperative

干预措施: dexmedetomidine (Drug)

结局指标

主要结局

the pain intensity measure

时间窗: 12 months

Self reported pain intensity in rest and activity will be recorded at day 1 before sugery, month 3, month 6, month 12 after sugery. The intensity of pain was measured by numeric rating scale (0=no pain, 10=worst possible pain)

次要结局

  • anxiety(12 months)
  • depression(12 months)
  • sleep disturbance(12 months)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jian-jun Yang

director, department of anesthesiology

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验